Sage Journals: Discover world-class research

Abstract

Get full access to this article

View all access options for this article.

References

Anderson

J. R.

Goudie

R. B.

Gray

K. G.

(1959). The ‘thyrotoxic’ complement-fixation reaction. Scot. med. J., 4, 64.

Aronson

A. R.

Montgomerv

M. M.

(1959). Chronic liver disease with a lupus erythematosus-like syndrome. Arch, intern. Med., 104, 544.

Barr

Buchananw

Doniach

Roitt

I. M.

(1961). To be published.

Bettley

F. R.

(1955). The L.E.-cell phenomenon in active chronic viral hepatitis. Lancet, 2, 724.

Buchanan

W. W.

Anderson

J. R.

Goudie

R. B.

Gray

K. G.

(1958). A skin test in thyroid disease. Lancet, 2, 928.

Buchanan

W. W.

Crooks

Alexander

W. D.

Koutras

D. A.

Wayne

E. J.

Gray

K. G.

(1961). Association of Hashimoto's thyroiditis and rheumatoid arthritis. Lancet, 1, 245.

Buchanan

W. W.

Koutras

D. A.

Alexander

W. D.

Crooks

Richmond

M. H.

Macdonald

E. M.

Wayne

E. J.

(1961). Iodine metabolism in Hashimoto's thyroiditis. J. clin. Endocr., 21, 806.

Crooks

Murray

I. P. C.

Wayne

E. J.

(1959). Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Quart. J. Med., 28, 211.

Cherrick

G. R.

Pothier

Dufour

J-J.

Sherlock

(1959). Immunologic response to tetanus toxoid inoculation in patients with hepatic cirrhosis. New Engl. J. Med., 261, 340.

10.

Doniach

Roitt

I. M.

Hudso

N. R. V.

(1959). Thyroidite d'auto-immunité associeé aux affections hépatiques. Rev. Foie, 34, 287.

11.

Farrell

L. P.

Richmond

M. H.

(1961). A rapid method for the estimation of serum protein-bound iodine. Clin. chim. Acta, 6, 620.

12.

Glenny

A. T.

Stevens

M. F.

(1938). Laboratory control of tetanus prophylaxis. J. roy. Army med. Cps., 70, 308.

13.

Goudie

R. B.

Anderson

J. R.

Gray

K. G.

Clark

D. H.

Murray

I. P. C.

McNicol

G. P.

(1957). Precipitin tests in thvroid disease. Lancet, 2, 976.

14.

Goudie

R. B.

Erson

J. R.

Gray

K. G.

(1959). Complement-fixing antithyroid antibodies in hospital patients with asymptomatic thvroid lesions. J. Path. Bad., 77, 389.

15.

Havens

W. P.

Jr. Shaffer

J. M.

Hopke

C. J.

Jr. (1951). Production of antibody by patientswith chronic hepatic disease. J. Immunol., 67, 347.

16.

Havens

W. P.

Jr. Myerson

R. M.

Klatchko

(1957). Production of tetanus antitoxin by patients with hepatic cirrhosis. New Engl. J. Med., 257, 637.

17.

Heller

Zimmerman

H. J.

Rozengvaig

Singer

(1956). The L.E.-cell phenomenon in chronic hepatic disease. New Engl. J. Med., 254, 1160.

18.

Holborow

E. J.

(1960). Serum anti-nuclear factor and auto-immunity. Proc. roy. Soc. Med., 53, 625.

19.

Koutras

D. A.

Alexander

W. D.

Buchanan

W. W.

Crooks

Wayne

E. J.

(1960). Stable iodine metabolism in thyroid dyshormonogenesis. Scot. med. J., 5, 331.

20.

Kydd

D. M.

Man

E. B.

(1951). Precipitable iodine of serum (SPI) in disorders of the liver. J. clin. Invest., 30, 874.

21.

Limbosch

(1959). Thyroidite fibrcuse avee alterations hepatiques et rénales concomitantes. Ann. Endocr. (Paris), 20, 500.

22.

Long

D. A.

(1957). The influence of the thyroid gland upon immune responses of different species to bacterial infection. Ciba Foundation Colloquia on Endrocrinology, 10, 287.

23.

Luxton

R. W.

Coke

R. T.

(1956). Hashimoto's struma lymphomatosa. Lancet, 2, 105.

24.

McConkey

Callaghan

(1960). Thyroiditis and cirrhosis of liver. Lancet, 1, 939.

25.

Macdonald

R. R.

Sharman

(1959). Cervical mucus in early pregnancy. Int. J. Fertil., 4, 338.

26.

Mackay

I. R.

Taft

L. I.

Cowling

D.C.

(1956). Lupoid hepatitis. Lancet, 2, 1323.

27.

Mackay

I. R.

Taft

L. I.

Cowling

D.C.

(1959). Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus. Lancet, 1, 65.

28.

Mackay

I. R.

(1960). Primary biliary cirrhosis. Lancet, 2, 521.

29.

Moses

Critchfield

F. H.

Thomas

T. H.

(1948). The importance of the rate of dye removed in the bromsulfalein test of liver function. J. Lab. Clin. Med., 33, 448.

30.

Roitt

I. M.

Doniach

(1958). Human autoimmune thyroiditis: Serological studies. Lancet, 2, 1027.

31.

Sclare

Nicol

Taylor

(1961). Hepatic cirrhosis and the thyroid. Lancet, 1, 922.

32.

Shipley

R. A.

Chudzik

E. S.

(1957). Thyroidal uptake and plasma clearance of ¹³¹ and ¹²⁷ in cirrhosis of the liver. J. clin. Endocr., 17, 1229.

33.

Taft

L. I.

Mackay

I. R.

Larkin

(1958). Hepatitis complicated by manifestations of lupus erythematosus. J. Path. Bact., 75, 399.

34.

Vannotti

Beraud

(1959). Functional relationships between the liver, the thyroxine-binding protein of serum, and the thyroid. J. clin. Endocr., 19, 466.

35.

Weir

D. M.

Holborow

E. J.

Johnson

G. D.

(1961). A clinical study of serum antinuclear factor. Brit. med. J., 1, 933.

36.

White

R. G.

Bass

B. H.

Williams

(1961). Lymphadenoid goitre and the syndrome of systemic lupus erythematosus. Lancet, 1, 368.

The Association of Auto-Immune Thyroiditis and Cirrhosis of the Liver

Abstract

Get full access to this article

References